Venous thromboembolism · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher venous thromboembolism (DVT or PE) compared with placebo (moderate certainty).
1 finding from 1 review
Venous thrombo‐embolism (DVT or PE): CEE 0.625 mg (moderate dose) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in venous thromboembolism (DVT or PE): CEE 0.625 mg (moderate dose) compared with placebo (moderate certainty).
1 finding from 1 review
Breast cancer · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in breast cancer compared with placebo (moderate certainty).
1 finding from 1 review
Gallbladder disease · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher gallbladder disease compared with placebo (moderate certainty).
1 finding from 1 review
All clinical fractures · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to lower all clinical fractures compared with placebo (moderate certainty).
1 finding from 1 review
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher stroke compared with placebo (moderate certainty).
1 finding from 1 review
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher stroke compared with placebo (moderate certainty).
1 finding from 1 review
Venous thromboembolism · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher venous thromboembolism (DVT or PE) compared with placebo (moderate certainty).
1 finding from 1 review
Breast cancer · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher breast cancer compared with placebo (moderate certainty).
1 finding from 1 review
Mortality: lung cancer · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher death from lung cancer compared with placebo (moderate certainty).
1 finding from 1 review
Gallbladder disease · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher gallbladder disease compared with placebo (moderate certainty).
1 finding from 1 review
All clinical fractures · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to lower all clinical fractures compared with placebo (moderate certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with menopausal hot flushes
1 finding from 1 review
Hot flush severity · women with menopausal hot flushes
1 finding from 1 review
Effect on later sexual function · symptomatic or early postmenopausal women1.
4 findings from 1 review
no estimate extracted
3 studies · 699 participants
Moderate
no estimate extracted
1 study · 883 participants
Very low
no estimate extracted
1 study · 215 participants
Very low
Show 1 more finding
Effect on later sexual function · Postmenopausal women
5 findings from 1 review
no estimate extracted
1 study · 272 participants
Very low
no estimate extracted
6 studies · 608 participants
Moderate
no estimate extracted
1 study · 104 participants
Very low
Show 2 more findings
Estrogen + progestogens · symptomatic or early postmenopausal women1.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine volume (cm³) · girls with Turner syndrome who were treated with prepubertal growth hormone
1 finding from 1 review